US Edition
News from Pharmacy Times
Top Pharmacy Times News
FDA · WilmingtonTUESDAY, Sept. 2, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Leqembi Iqlik, a subcutaneous version of lecanemab, for weekly maintenance after the 18-month intravenous (IV) phase.See the Story
FDA Approves Subcutaneous Leqembi for Treatment of Early Alzheimer Disease
42% Center coverage: 19 sources
Innovation · ChicagoCHICAGO, Sept. 1, 2025 /PRNewswire/ -- In a groundbreaking milestone for global healthcare and pharmaceutical innovation, Professor Sarfaraz K. Niazi, Adjunct Professor at the University of Illinois at Chicago and founder of multiple biopharmaceutical enterprises, has secured the first-ever FDA…See the Story
Professor Sarfaraz K. Niazi Secures First-Ever FDA Acceptance to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars
89% Center coverage: 9 sources
Donald TrumpA German clinical trial reveals that over-the-counter azelastine nasal spray significantly reduces COVID-19 infections when used three times daily for prevention.See the Story
COVID-19 Infection Risk Cut 'Significantly' with Simple Nasal Spray, Research Finds
100% Right coverage: 2 sources
